Skip to main content

Research Repository

Advanced Search

Pseudomonas aeruginosa quorum sensing systems as drug discovery targets: current position and future perspectives

Soukarieh, Fadi; Williams, Paul; Stocks, Michael John; Camara, Miguel

Pseudomonas aeruginosa quorum sensing systems as drug discovery targets: current position and future perspectives Thumbnail


Authors

PAUL WILLIAMS PAUL.WILLIAMS@NOTTINGHAM.AC.UK
Professor of Molecular Microbiology

MICHAEL STOCKS MICHAEL.STOCKS@NOTTINGHAM.AC.UK
Professor of Medicinal Chemistry and Drug Discovery

Profile Image

MIGUEL CAMARA MIGUEL.CAMARA@NOTTINGHAM.AC.UK
Professor of Molecular Microbiology



Abstract

Antimicrobial resistance (AMR) is a serious threat to public health globally, manifested by the frequent emergence of multi-drug resistant pathogens that render current chemotherapy inadequate. Health organizations worldwide have recognized the severity of this crisis and implemented action plans to contain its adverse consequences and prolong the utility of conventional antibiotics. Hence, there is a pressing need for new classes of antibacterial agents with novel modes of action. Quorum sensing (QS), a communication system employed by bacterial populations to co-ordinate virulence gene expression, is a potential target that has been intensively investigated over the last decade. This Perspective will focus on recent advances in targeting the three main quorum sensing systems (las, rhl and pqs) of a major opportunistic human pathogen, Pseudomonas aeruginosa, and will specifically evaluate the medicinal chemistry strategies devised to develop QS inhibitors from a drug discovery perspective.

Citation

Soukarieh, F., Williams, P., Stocks, M. J., & Camara, M. (in press). Pseudomonas aeruginosa quorum sensing systems as drug discovery targets: current position and future perspectives. Journal of Medicinal Chemistry, https://doi.org/10.1021/acs.jmedchem.8b00540

Journal Article Type Article
Acceptance Date Jul 12, 2018
Online Publication Date Jul 12, 2018
Deposit Date Jul 25, 2018
Publicly Available Date Mar 28, 2024
Journal Journal of Medicinal Chemistry
Print ISSN 0022-2623
Electronic ISSN 1520-4804
Publisher American Chemical Society
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1021/acs.jmedchem.8b00540
Public URL https://nottingham-repository.worktribe.com/output/946598
Publisher URL https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00540